[Glibenclamide as a promising agent for prevention and treatment of cerebral edema].
The article presents a review of the literature on the use of a fundamentally new technique for prevention and treatment of cerebral edema.  A drug glibenclamide, which is used to treat type 2 diabetes mellitus, is able to reduce cerebral edema and neuronal damage as evidenced by the results of preclinical trials in rodents and the first results of drug application in patients.
The article describes the mechanism of glibenclamide action and discusses the potential for its application.
